Publications

FIRST-IN-HUMAN, SINGLE- AND MULTIPLE-ASCENDING-DOSE, FOOD-EFFECT, AND ABSOLUTE BIOAVAILABILITY TRIALS TO ASSESS THE PHARMACOKINETICS, SAFETY, AND TOLERABILITY OF PRITELIVIR, A NONNUCLEOSIDE HELICASE-PRIMASE INHIBITOR AGAINST HERPES SIMPLEX VIRUS IN HEALTHY SUBJECTS

Kropeit D., Bonsmann S., von Richter O., McCormick D., Pausch J., Sumner M., Birkmann A., Zimmermann H., Rübsamen-Schaeff H.

Clin Pharmacol Drug Dev. 2023 Mar 1. doi: 10.1002/cpdd.1241


DISCOVERY, CHEMISTRY, AND PRECLINICAL DEVELOPMENT OF PRITELIVIR, A NOVEL TREATMENT OPTION FOR ACYCLOVIR-RESISTANT HERPES SIMPLEX VIRUS INFECTIONS

Birkmann, A., Bonsmann, S., Kropeit, D., Pfaff, T., Rangaraju, M., Sumner, M., Timmler, B., Zimmermann, H., Buschmann, H., & Ruebsamen-Schaeff, H.

J Med Chem . 2022 Oct 6. doi: 10.1021/acs.jmedchem.2c00668


RISK FACTORS FOR TREATMENT FAILURE AND MORTALITY AMONG HOSPITALIZED PATIENTS WITH COMPLICATED URINARY TRACT INFECTION: A MULTICENTER RETROSPECTIVE COHORT STUDY (RESCUING STUDY GROUP).

Eliakim-Raz N, Babitch T, Shaw E, Addy I, Wiegand I, Vank C, Torre-Vallejo L, Joan-Miquel V, Steve M, Grier S, Stoddart M, Nienke C, Leo VDH, Vuong C, MacGowan A, Carratalà J, Leibovici L, Pujol M; RESCUING Study Group.

Clin Infect Dis. 2019 Jan 1;68(1):29-36. doi: 10.1093/cid/ciy418.


Effect of Pritelivir Compared With Valacyclovir on Genital HSV-2 Shedding in Patients With Frequent Recurrences: A Randomized Clinical Trial.

Wald A, Timmler B, Magaret A, Warren T, Tyring S, Johnston C, Fife K, Selke S, Huang ML, Stobernack HP, Zimmermann H, Corey L, Birkmann A, Ruebsamen-Schaeff H.

JAMA. 2016 Dec 20;316(23):2495-2503. doi: 10.1001/jama.2016.18189.